Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-13680132

RESUMO

Extracellular nucleotides are ubiquitous signaling molecules. ATP signals through two receptor types: the ionotropic P2X receptors, and the metabotropic P2Y receptors. ATP acts as a chemorepellent in Tetrahymena thermophila, where it causes a distinct avoidance response. The intracellular mechanisms by which ATP causes avoidance in this organism, however, are unknown. In this study, we use in vivo pharmacological assays along with enzyme immuno-assays to obtain information about the ATP chemorepellent pathway and its associated second messenger systems. Our data show strong similarities between the presumed ATP receptor of T. thermophila and members of the P2Y family of receptors. The ATP response of T. thermophila appears to be coupled to phospholipase C, a defining characteristic of the P2Y receptor family. In addition, the ATP chemoresponse appears to be linked to a G(i/o) protein, nitric oxide synthase, and adenylyl cyclase, all of which are characteristic of some P2Y receptors. This is an important first step in describing the pathways involved in ATP chemoresponse of this organism.


Assuntos
Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/metabolismo , Ácido Egtázico/análogos & derivados , Guanosina Difosfato/análogos & derivados , Receptores Purinérgicos P2/metabolismo , Tetrahymena thermophila/metabolismo , Trifosfato de Adenosina/farmacologia , Animais , Comportamento Animal , Quelantes/farmacologia , Relação Dose-Resposta a Droga , Ácido Egtázico/farmacologia , Inibidores Enzimáticos/farmacologia , Ensaio de Imunoadsorção Enzimática , Reação de Fuga/efeitos dos fármacos , Guanosina Difosfato/farmacologia , Toxina Pertussis/farmacologia , Receptores Purinérgicos P2/química , Sistemas do Segundo Mensageiro/efeitos dos fármacos , Tetrahymena thermophila/citologia , Tionucleotídeos/farmacologia
2.
J Comp Physiol A ; 187(3): 171-6, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11401196

RESUMO

Pituitary adenylate cyclase-activating peptide and lysozyme are potent chemorepellents which act through the same receptor in Tetrahymena. Using in vivo behavioral studies, we have found that the pituitary adenylate cyclase-activating peptide/lysozyme receptor appears to signal through a G-protein pathway which is mediated through both adenosine 3'5'monophosphate and protein kinase C. Avoidance to pituitary adenylate cyclase-activating peptide and lysozyme is inhibited by the G-protein inhibitor, guanosine 5'-O-(2thiodiphosphate), the adenosine 3'5'monophate analog, Rp-adenosine-3', 5' cyclic monophosphorothioate, and the protein kinase C inhibitors, calphostin C and bisindolylmaleimide IV. A proposed model for signaling through the pituitary adenylate cyclase-activating peptide/lysozyme receptor is briefly outlined.


Assuntos
AMP Cíclico/farmacologia , Locomoção , Neuropeptídeos/farmacologia , Proteína Quinase C/farmacologia , Tetrahymena thermophila/fisiologia , Animais , Comportamento Animal , Células Quimiorreceptoras , Muramidase/farmacologia , Polipeptídeo Hipofisário Ativador de Adenilato Ciclase
3.
J Comp Physiol A ; 186(1): 39-43, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10659041

RESUMO

Pituitary adenylate cyclase activating peptide (PACAP-38) is a peptide hormone which functions in many mammalian systems, including the nervous and digestive systems. Using in vivo behavioral studies, we have found that this hormone functions as a chemore-pellent in Tetrahymena thermophila with an EC50 of 10 nM. Cells previously adapted to PACAP-38 were found to be adapted to lysozyme and vice versa. Furthermore, the in vivo behavioral activity of PACAP-38 was blocked by addition of the anti-lysozyme receptor antibody, 5545. Chemorepellent activity of PACAP-38 was also inhibited by the addition of neomycin sulfate (inhibition constant Ki = 0.080 micromol x l(-1)), a competitive inhibitor of lysozyme binding to its receptor. PACAP-38 is a more potent and specific agonist for the lysozyme receptor than either intact lysozyme or CB2, a 24-amino acid fragment of lysozyme.


Assuntos
Neuropeptídeos/farmacologia , Neurotransmissores/farmacologia , Receptores do Hormônio Hipofisário/metabolismo , Tetrahymena thermophila/efeitos dos fármacos , Adaptação Fisiológica/efeitos dos fármacos , Animais , Anticorpos/farmacologia , Comportamento Animal/efeitos dos fármacos , Reações Cruzadas , Muramidase/farmacologia , Neomicina/farmacologia , Polipeptídeo Hipofisário Ativador de Adenilato Ciclase , Inibidores da Síntese de Proteínas/farmacologia , Proteínas de Protozoários/imunologia , Proteínas de Protozoários/metabolismo , Receptores de Polipeptídeo Hipofisário Ativador de Adenilato Ciclase , Receptores do Hormônio Hipofisário/agonistas , Receptores do Hormônio Hipofisário/imunologia , Sistemas do Segundo Mensageiro/efeitos dos fármacos , Transdução de Sinais/fisiologia , Tetrahymena thermophila/química
5.
J Comp Physiol A ; 184(5): 529-34, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10377982

RESUMO

While lysozyme is a depolarizing chemorepellent in Tetrahymena, the entire lysozyme molecule is not necessary to activate the lysozyme receptor. Reduced lysozyme was cut into three fragments by cyanogen bromide cleavage and the fragments (CB1, CB2 and CB3) were separated by HPLC. Behavioral bioassays showed that the carboxy-terminal 24-amino-acid fragment, which we call CB2, is 100 times more active than intact lysozyme as a chemorepellent. CB2 appears to activate the same receptor as lysozyme because behavioral cross-adaptation is seen between these two compounds and an antibody generated to the purified lysozyme receptor blocks responses to both lysozyme and CB2. This is further supported by the observation that neomycin, which is a competitive inhibitor of lysozyme binding, also inhibits CB2 responses. This inhibition may be due to the fact that neomycin is highly positively charged (+5 at pH 7.0) and CB2 has a net charge of +4 at pH 7.0. Intracellular electrophysiological recordings documented that CB2 elicits a transient, depolarizing receptor potential that is similar to the lysozyme-induced depolarizations except they are much smaller. CB2 is a more potent and specific ligand for use in studies of the lysozyme receptor of Tetrahymena.


Assuntos
Comportamento Animal/efeitos dos fármacos , Células Quimiorreceptoras/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Tetrahymena thermophila/fisiologia , Sequência de Aminoácidos , Animais , Potenciais da Membrana/fisiologia , Dados de Sequência Molecular , Neomicina/farmacologia , Técnicas de Patch-Clamp , Inibidores da Síntese de Proteínas/farmacologia
6.
J Membr Biol ; 162(1): 51-7, 1998 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-9516237

RESUMO

Chemosensory transduction and adaptation are important aspects of signal transduction mechanisms in many cell types, ranging from prokaryotes to differentiated tissues such as neurons. The eukaryotic ciliated protozoan, Tetrahymena thermophila, is capable of responding to both chemoattractants (O'Neill et al., 1985; Leick, 1992; Kohidai, Karsa & Csaba, 1994, 1995) and chemorepellents (Francis & Hennessey, 1995; Kuruvilla, Kim & Hennessey, 1997). An example of a nontoxic, depolarizing chemorepellent in Tetrahymena is extracellular lysozyme (Francis & Hennessey, 1995; Hennessey, Kim & Satir, 1995). Lysozyme is an effective chemorepellent at micromolar concentrations, binds to a single class of externally facing membrane receptors and prolonged exposure (10 min) produces specific chemosensory adaptation (Kuruvilla et al., 1997). We now show that this lysozyme response is initiated by a depolarizing chemoreceptor potential in Tetrahymena and we have purified the membrane lysozyme receptor by affinity chromatography of solubilized Tetrahymena membrane proteins. The solubilized, purified protein is 42 kD and it exhibits saturable, high affinity lysozyme binding. Polyclonal antibodies raised against this 42 kD receptor block the in vivo lysozyme chemoresponse. This is not only the first time that a chemoreceptor potential has been recorded from Tetrahymena but also the first time that a chemorepellent receptor has been purified from any unicellular eukaryote.


Assuntos
Muramidase/metabolismo , Receptores de Superfície Celular/metabolismo , Tetrahymena thermophila/metabolismo , Sequência de Aminoácidos , Animais , Cálcio/farmacologia , Dados de Sequência Molecular , Receptores de Superfície Celular/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...